Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACEI; angiotensin-converting enzyme inhibitor; NHI; National Health Insurance;
مقالات ISI مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACE-I; angiotensin-converting enzyme inhibitor; ARB; angiotension receptor blocker; BMI; body mass index; Cr; creatinine; CVD; cardiovascular disease; DPP-4; dipeptidyl peptidase 4; GAD-65; glutamic acid decarboxylase; GLP-1; glucagon-like peptide 1; GFR;
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Heart failure; Congenital heart disease; Medical therapy; β-blockers; Angiotensin-converting enzyme inhibitor;
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACCF; American College of Cardiology Foundation; ACE-I; angiotensin-converting enzyme inhibitor; AHA; American Heart Association; ADHF; acute decompensated HF; CRT; cardiac resynchronization therapy; DAD-HF; Dopamine in Acute Decompensated Heart Failure;
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Anaphylaxis; antihypertensive medications; angiotensin-converting enzyme inhibitor; beta-blocker; risk factors; emergency department; ACE; Angiotensin-converting enzyme; CCB; Calcium channel blocker; ED; Emergency department; NIAID/FAAN; National Institut
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; AF; atrial fibrillation; MetS; metabolic syndrome; DM; diabetes mellitus; LAD; left atrial diameter; LVEF; left ventricular ejection fraction; ARB; angiotensin II receptor blockers; ACEI; angiotensin-converting enzyme inhibitor; LRAF; late recurrence of A
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; cost-effectiveness; heart failure; medications; ACEI; angiotensin-converting enzyme inhibitor; AldA; aldosterone antagonists; BB; beta-blocker; HF; heart failure; HFrEF; heart failure with reduced ejection fraction; ICER; incremental cost-effectiveness ra
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Pulse wave velocity; Arterial stiffness; Augmentation index; Target organ damage; Hypertension guidelines; Angiotensin-converting enzyme inhibitor; Calcium channel blocker
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angioedema; Angiotensin-converting enzyme inhibitor; Respiratory failure
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; Fibrosis; Muscular dystrophy; Duchenne muscular dystrophy; Becker muscular dystrophy; Myotonic dystrophy; Emery-Dreifuss muscular dystrophy; Heart failure; Dystrophinopathic cardiomyopathy;
Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Hereditary angioedema; Normal C1 inhibitor; F12 mutations; Estrogen; Brazilian population; ACEI; Angiotensin-converting enzyme inhibitor; C1-INH; C1 inhibitor; C1-INH-HAE; Hereditary angioedema with C1 inhibitor deficiency; eOC; Estrogen-containing oral c
Medical Therapy for Heart Failure With Reduced Ejection Fraction
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; dose; medication; reduced ejection fraction; registry; ACEI; angiotensin-converting enzyme inhibitor; ARB; angiotensin II receptor blocker; ARNI; angiotensin receptor-neprilysin inhibitor; GDMT; guideline-directed medical therapy; HF; heart failure; HFrEF
A novel S-nitrosocaptopril monohydrate for pulmonary arterial hypertension: H2O and -SNO intermolecular stabilization chemistry
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Cap; captopril; CapNO; S-Nitrosocaptopril; CapNO·H2O; S-Nitrosocaptopril monohydrate; NO; nitric oxide; ACEI; angiotensin-converting enzyme inhibitor; -SH; sulfhydryl; -SNO; S-nitroso; RSNO; S-Nitrosothiol or thionitrite; sGC; soluble Guanylate Cycla
Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Acquired angioedema; C1-INH deficiency; Prevalence; Treatment; Diagnosis; Plasma-derived C1-inhibitor; Icatibant; ACE-I; Angiotensin-converting enzyme inhibitor; C1-INH; C1-inhibitor; C1-INH-AAE; Acquired angioedema due to C1-inhibitor deficiency; C1-INH-
Evolution of Functional Mitral Regurgitation and Prognosis in Medically Managed Heart Failure Patients With Reduced Ejection Fraction
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; functional mitral regurgitation; heart failure; medical management; ACEI; angiotensin-converting enzyme inhibitor; AHT; arterial hypertension; ARB; angiotensin receptor blocker; CRT; cardiac resynchronization therapy; FMR; functional mitral regurgitation
Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; blood pressure; heart failure; heart failure with reduced ejection fraction; heart failure with preserved ejection fraction; J-curve; mortality; AA; aldosterone antagonist; ACEI; angiotensin-converting enzyme inhibitor; ANOVA; 1-way analysis of variance m
Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; community detection; medication nonadherence; pharmacological intervention; randomized controlled trial; stage B heart failure; A; peak late diastolic velocity; ACEi; angiotensin-converting enzyme inhibitor; AE; advanced echocardiography arm; AF; atrial f
Controversies in Perioperative Medicine
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Perioperative; Myocardial infarction; Angiotensin-converting enzyme inhibitor; Angiotensin receptor blocker; Comanagement service; Insulin management; Tobacco use; Obstructive sleep apnea;
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; angiotensin II; angiotensin-(1-7); chymase; dilated cardiomyopathy; renin-angiotensin system; ACE; angiotensin-converting enzyme; ACEI; angiotensin-converting enzyme inhibitor; AHF; acute heart failure; Ang I; angiotensin-(1-10); Ang II; angiotensin-(
Moving pieces in a cryptomic puzzle: Cryptide from Tityus serrulatus Ts3 Nav toxin as potential agonist of muscarinic receptors
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACE; angiotensin-converting enzyme; ACEi; angiotensin-converting enzyme inhibitor; ACh; acetylcholine; BK; bradykinin; BPP; bradykinin-potentiating peptide; Hip; N-hippuryl; mAChR; muscarinic acetylcholine receptor; NO; nitric oxide; NOS; nitric oxide syn
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; Calcium channel blocker; Diuretics; Hypertension; Resistance;
2016 update to The American Association for Thoracic Surgery (AATS) consensus guidelines: Ischemic mitral valve regurgitation
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; 3D; 3-dimensional; AATS; The American Association for Thoracic Surgery; ACC; American College of Cardiology; ACCF; American College of Cardiology Foundation; ACE-I; angiotensin-converting enzyme inhibitor; AHA; American Heart Association; CABG; coronary a
Neprilysin Inhibition in the Time of Precision Medicineâ
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; age-related macular degeneration; Alzheimer's disease; angiotensin-converting enzyme inhibitor; heart failure; neprilysin;
Kidney Disease Progression in Autosomal Recessive Polycystic Kidney Disease
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; A/H/D; Aplastic/hypoplastic/dysplastic disorder; ACEI; Angiotensin-converting enzyme inhibitor; ARPKD; Autosomal recessive polycystic kidney disease; CKD; Chronic kidney disease; CKiD; Chronic Kidney Disease in Children; CT; Collecting tubule; eGFR; Estim
Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Anthracycline; Chronic cardiomyopathy; Angiotensin-converting enzyme inhibitor; Peroxisome proliferator-activated receptors; Myosin heavy chain isoforms
Urinary peptidomics provides a noninvasive humanized readout of diabetic nephropathy in mice
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; angiotensin-converting enzyme inhibitor; albuminuria; diabetic nephropathy; proteomic analysis; urine;
Bioassay-guided preparative separation of angiotensin-converting enzyme inhibitory C-flavone glycosides from Desmodium styracifolium by recycling complexation high-speed counter-current chromatography
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; Bioactivity-guided fractionation; C-flavone glycosides; Desmodium styracifolium; High-speed counter-current chromatography;
Changes in Drug Utilization and Outcome With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Heart failure; resynchronization; diuretic; angiotensin-converting enzyme inhibitor; angiotensin receptor blocker
Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; cardiovascular disease; chronic disease care; nurse practitioners; performance measures; physician assistants; physicians; ACA; Affordable Care Act; ACC; American College of Cardiology; ACE-I; angiotensin-converting enzyme inhibitor; AF; atrial fibrillati
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; hypertension; natriuretic peptide; renin; ACEi; angiotensin-converting enzyme inhibitor; ADM; adrenomedullin; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; ARNi; angiotensin receptor antagonist-neprilysin inhibitor; BNP; B-type natr
Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores: An Analysis of Mortality and Morbidity in PARADIGM-HF
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; angiotensin receptor neprilysin inhibitor; prognostic model; risk score; survival; ACEI; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; ARB; angiotensin receptor blocker; BMI; body mass index; BNP; B-type natriuretic peptide; eGFR; esti
Challenges and solutions in medically managed ACS in the Asia-Pacific region: Expert recommendations from the Asia-Pacific ACS Medical Management Working Group
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACACIA; Australian Acute Coronary Syndromes Prospective Audit; ACCORD; ACute CORonary syndromes Descriptive study; ACCF; American College of Cardiology Foundation; ACEi; angiotensin-converting enzyme inhibitor; ACS; acute coronary syndromes; ADPi; adenosi
Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACE-I; angiotensin-converting enzyme inhibitor; ACM; adult cardiomyocytes; Aldo; aldosterone; ARB; angiotensin receptor blockers; ANF; atrial natriuretic factor; AP-1; activator protein-1; BSA; bovine serum albumin; CF; cardiac fibroblasts; CT-1; cardiotr
Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; Blood pressure; Enalapril; Enalaprilat; Horses
Targeting inflammation: New therapeutic approaches in chronic kidney disease (CKD)
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACEI; Angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; CKD; chronic kidney disease; DN; diabetic nephropathy; ESRD; end stage renal disease; PEA; palmitoylethanolamide; PPARα; proliferator activated receptor alpha; TNF-α; tumo
Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; AG; American ginseng; AI; augmentation index; BP; blood pressure; CAM; complementary and alternative medicine; NO; nitric-oxide; CVD; cardiovascular disease; HbA1c; glycated hemoglobin; FPG; fasting plasma glucose; IQOLA SF-36v2; international quality of
COPD in chronic heart failure: Less common than previously thought?
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Chronic heart failure; Chronic obstructive pulmonary disease; Prevalence; Fixed ratio; Lower limit of normal; ABHR; aspecific bronchial hyperreactivity; ACE-I; angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; ATS/ERS; American T
Changing Referral Characteristics of Patients with Autosomal Dominant Polycystic Kidney Disease
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; Blood pressure; Chronic kidney disease; Renal progression;
L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACEI; angiotensin-converting enzyme inhibitor; ACS; acute coronary syndrome; AMI; acute myocardial infarction; BB; β-blocker; CEDIM 2; Carnitine Ecocardiografia Digitalizzata Infarto Miocardico 2; CV; cardiovascular; HF; heart failure; LV; left ventricul
Effect of β-Blockers and Other Antihypertensive Drugs On the Risk of Melanoma Recurrence and Death
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACEI; angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; CMM; cutaneous malignant melanoma; DFS; disease-free survival; HR; hazard ratio; OS; overall survival;
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; ACEI; Angiotensin receptor blocker; ARB
Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; angioedema; pollen; bradykinin; substance P; seasonal allergies; ACE; Angiotensin-converting enzyme; ONTARGET; Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial;
Combined Use of the Novel Biomarkers High-Sensitivity Troponin T and ST2 for Heart Failure Risk Stratification vs Conventional Assessment
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACEI; angiotensin-converting enzyme inhibitor; AIC; Akaike information criterion; ARB; angiotensin II receptor blocker; AUC; area under the receiver operating characteristic curve; BIC; Bayesian information criterion; eGFR; estimated glomerular filtration
A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACE-I; angiotensin-converting enzyme inhibitor; angiotensin receptor blocker; ARB; clinical eventsACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CI, confidence interval; CV, cardiovascular; DM, diabetes mellitus; HF, he
My Approach to the Treatment of Scleroderma
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACE; angiotensin-converting enzyme inhibitor; ATG; antithymocyte globulin; DU; digital ulcer; FVC; forced vital capacity; HRCT; high-resolution computed tomography; HSCT; hematopoietic stem cell transplantation; ILD; interstitial lung disease; PAH; pulmon
National Observatory on the Therapeutic Management in Ambulatory Care Patients Aged 65 and Over, with Type 2 Diabetes, Chronic Pain or Atrial Fibrillation
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; aged; type 2 diabetes mellitus; atrial fibrillation; chronic pain; pharmacoepidemiology; sujets agés; diabète de type 2; fibrillation auriculaire; douleur chronique; pharmaco épidemiologie; ACE; angiotensin-converting enzyme inhibitor; ADL; activity of
A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Angiotensin-converting enzyme inhibitor; acquired C1 inhibitor deficiency; angioedema; angiotensin receptor blocker; bradykinin; C1 inhibitor deficiency; hereditary angioedema;
Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; ACE-I; angiotensin-converting enzyme inhibitor; ADMA; asymmetric dimethylarginine; AMI; acute myocardial infarction; ARB; angiotensin II receptor blocker; ATP; adenosine triphosphate; DBP; diastolic blood pressure; HDL-C; high-density lipoprotein choleste
Renin–angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; Pacemaker; Survival; Heart failure; Angiotensin-converting enzyme inhibitor; Angiotensin receptor blockerACEI, angiotensin-converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin receptor blocker; AV, atrioventricular; CI, confidence interv
Bone marrow stromal cell transplantation combined with angiotensin-converting enzyme inhibitor treatment in rat with acute myocardial infarction and the role of insulin-like growth factor-1
Keywords: مهارکننده آنزیم تبدیل‌کننده آنژیوتانسین; acute myocardial infarction; angiotensin-converting enzyme inhibitor; bone marrow stromal cells; insulin-like growth factor-1